OIE Procedure for Validation and Certification of Diagnostic Assays
|
|
|
- Sylvia Morris
- 6 years ago
- Views:
Transcription
1 OIE Procedure for Validation and Certification of Diagnostic Assays A FRAMEWORK FOR A HARMONISED APPROACH OF THE VALIDATION AND REGISTRATION OF VETERINARY DIAGNOSTIC ASSAYS ACROSS THE WORLD OIE Conference on Veterinary Medicinal Products in the Middle East, Damascus, Syria, December 2009 Dr François Diaz OIE Scientific and Technical Department
2 Introduction OIE Guidelines and General Principles regarding validation of veterinary diagnostic test methods OIE Procedure for the validation and certification of diagnostic assays Conclusions
3 OIE Guidelines and General Principles for validation of diagnostic test methods
4 The relevant OIE Publications Manual of diagnostic tests and vaccines for terrestrial animals (chapter 1.1.4/5 on Principles and Methods of Validation of Diagnostic Assays for Infectious Diseases ) Manual of diagnostic tests for aquatic animals (chapter identical to the chapter 1.1.4/5 of the Terrestrial Manual) OIE Quality Standard and Guidelines for Veterinary Laboratories: Infectious Diseases (4 Guides)
5 Chapter 1.1.4/5 of the OIE Terrestrial Manual and of the Aquatic Manual New chapter resulting from the fusion of the two previous chapters on the validation. 7 Appendixes are in development. Chapter available and downloadable on the OIE website:
6 OIE Quality standard and Guidelines for Veterinary Laboratories OIE quality standard for veterinary laboratories + 4 Guides: 1. Validation of Diagnostic Assays for Infectious Diseases 2. Validation and Quality Control of PCR Methods used for the Diagnosis of Infectious Diseases 3. International Reference Antibody Standards for Antibody Assays 4. Laboratory Proficiency Testing
7 OIE Quality standard and Guidelines for Veterinary Laboratories According to this OIE quality standard: A test method shall be considered appropriate for routine diagnostic purposes only if it has been validated according to the principles outlined in the OIE Manual and other related OIE references
8 Content of the OIE Guidelines and General Principles Definition of the validation: The validation of a diagnostic test method is a process that determines the fitness of the test method, which has been properly developed, optimised and standardised, for an intended purpose. It is an ongoing process.
9 Content of the OIE Guidelines and General Principles The most common purposes are to: Demonstrate freedom from infection in a defined population (country/zone/compartment/herd) Free with and/or without vaccination, Historical freedom, Reestablishment of freedom after outbreaks Certify freedom from infection or presence of the agent in individual animals or products for trade/movement Eradication of diseases or elimination of infection from defined populations Confirmatory diagnosis of suspect or clinical cases Estimate prevalence of infection or exposure to facilitate risk analysis Determine immune status of individual animals or populations
10 Content of the OIE Guidelines and General Principles OIE validation pathway: 4 stages defined The validation includes estimates of the analytical and diagnostic performance characteristics of a test. The OIE has defined the following chronological validation pathway: Stage 1 : Analytical performance characteristics Stage 2 : Diagnostic performance of the assay Stage 3 : Reproducibility Stage 4 : Programme implementation
11 Content of the OIE Guidelines and General Principles Stage 1 : Analytical performance characteristics Analytical sensitivity : smallest detectable amount of analyte that can be measured with a defined certainty Analytical specificity : Degree to which the assay distinguishes between the target analyte and other components in the sample matrix Repeatability: Level of agreement between replicates of a sample both within and between runs of the same test method in a given laboratory
12 Content of the OIE Guidelines and General Principles Stage 2 : Diagnostic performance of the assay Selection of reference animals Diagnostic specificity : Proportion of known uninfected reference animals that test negative in the assay Diagnostic sensitivity : Proportion of known infected reference animals that test positive in the assay Comparison with existing diagnostic test Final Threshold determination
13 Content of the OIE Guidelines and General Principles Stage 3 : Reproducibility Definition: ability of a test method to provide consistent results when applied to aliquots of the same samples tested at different laboratories Provides additional data for the estimation of the repeatability Provides data on the ruggedness if the test method has been developed as a diagnostic kit.
14 Content of the OIE Guidelines and General Principles Stage 4 : Programme implementation Extensive application of the test method in different laboratories Organisation of regular proficiency testing Monitoring the assay Consideration for other purposes
15 Fitness of Assay for its Intended Purpose Assay Development Pathway Essential Prerequisites Study Design and Protocol Reagents and Controls Optimization, Robustness, Calibration to Standards Analytical Specificity Analytical Sensitivity Provisional Recognition STAGE 1 Analytical characteristics Repeatability and preliminary Reproducibility Candidate test compared with Standard Test Method Assay Validation Pathway Diagnostic Analytical Specificity Diagnostic Sensitivity Cut-off determination STAGE 2 Diagnostic characteristics Samples from reference animals Samples from experimental animals (where used) Select collaborating Labs STAGE 3 Reproducibility Define evaluation panel Reproducibility Ruggedness Interpretation of test results Deployment to other Labs STAGE 4 Implementation Reference standards selected International recognition (OIE) Validation status retention Replacement of depleted reagents Assay modifications and re-validation Equivalency assessments Monitoring and maintenance of validation criteria Monitor precision and accuracy Daily in-house QC Proficiency testing
16 OIE Procedure for the validation and certification of diagnostic assays
17 Aim and Scope of the Procedure Developed to meet the needs of OIE Member, the aim of this procedure is: 1. to certify a kit as validated fit for purpose. 2. to produce an OIE register of recognised diagnostic kits (available on the OIE web site). All diagnostic tests for diseases, including zoonosis, caused by pathogens present in animals can be validated and certified by the OIE procedure.
18 OIE Procedure for validation and certification of diagnostic assays Briefly 1/2 Procedure based on the submission of a dossier by a kit manufacturer wishing to have the kit certified by the OIE Dossier, that has to be filled in, downloadable from the OIE website The data in the dossier are presented according to the 4 stages defined by the OIE for the validation of a test method.
19 OIE Procedure for validation and certification of diagnostic assays Briefly 2/2 Administrative revision to check if the dossier is complete Scientific evaluation of the dossier by a group of 2 3 independent and internationally recognised experts If the kit goes successfully through the procedure, it is proposed by the Biological Standards Commission for inclusion in the Register to the vote of the World Assembly of Delegates OIE Register currently comprises 5 diagnostic kits certified (kits for Rabies, BSE/TSE, White Spot Disease, AI)
20 OIE Procedure for validation and certification of diagnostic assays Outline of all the process Applicant Contact Dossier + Fees OIE Secretariat for the Procedure Validation of content of the dossier Appoint assessors Additional information 30 d Further assesment Assessment Meeting of the BSC 135d Decision Notification Appeals procedure Inclusion on the OIE Register
21 OIE Register available on the OIE Web site
22 Conclusions Framework for a harmonised approach across the world Keep on improving, when relevant, the OIE Guidelines and Principles and the Procedure Keep on encouraging application of the OIE Standards
23 Thank you for your attention Organisation Mondiale de la Santé Animale World Organisation for Animal Health Organización Mundial de Sanidad Animal 12 rue de Prony, Paris, France - oie@oie.int
OIE Standard on principles and methods of validation of diagnostic assays for infectious diseases
OIE Standard on principles and methods of validation of diagnostic assays for infectious diseases OIE Regional Workshop for OIE National Focal Points for Veterinary Products Maputo, Republic of Mozambique
i) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans.
The OIE Validation Recommendations provide detailed information and examples in support of the OIE Validation Standard that is published as Chapter 1.1.6 of the Terrestrial Manual, or Chapter 1.1.2 of
Reminder (VICH charter)
Dr. Marie Hendrickx Head of EU Pharmacovigilance Pfizer Animal Health IFAH Europe Representative VICH Electronic Standards Implementation Expert Working Group VICH Workshop Presentation of 2 Pharmacovigilance
The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual.
The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual. Absorbance, also termed optical density (OD), describes the
QUALITY MANAGEMENT IN VETERINARY TESTING LABORATORIES
CHAPTER 1.1.1. QUALITY MANAGEMENT IN VETERINARY TESTING LABORATORIES SUMMARY Valid laboratory results are essential for diagnosis, surveillance, and trade. Such results may be achieved by the use of good
PRINCIPLES OF VALIDATION OF DIAGNOSTIC ASSAYS FOR INFECTIOUS DISEASES
CHAPTER 1.1.4. PRINCIPLES OF VALIDATION OF DIAGNOSTIC ASSAYS FOR INFECTIOUS DISEASES INTRODUCTION Validation is the evaluation of a process to determine its fitness for a particular use and includes assay
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2015 This report has been submitted : 2016-01-14 02:24:46 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Classical
PROCEDURE FOR OFFICIAL RECOGNITION OF DISEASE STATUS UPDATE ON FOOT AND MOUTH DISEASE
PROCEDURE FOR OFFICIAL RECOGNITION OF DISEASE STATUS UPDATE ON FOOT AND MOUTH DISEASE Introduction In 1994, Member Countries gave the World Organisation for Animal Health (OIE) the responsibility of compiling
OIE Guideline. 1. Introduction
OIE Guideline INTERNATIONAL REFERENCE STANDARDS FOR ANTIGEN DETECTION ASSAYS 1. Introduction 1.1. Purpose This document provides guidelines for the preparation, validation and distribution of antigens
OIE Guideline. International Reference Antibody Standards for Antibody Assays. 1. Introduction
OIE Guideline International Reference Antibody Standards for Antibody Assays 1. Introduction 1.1. Purpose This document provides guidelines for the preparation, validation and distribution of antibodies
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-05-18 07:24:55 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Infection
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2016-12-11 14:12:34 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Avian
ILAC Mutual Recognition Arrangement: Policy and Management ILAC-P4:06/2017
ILAC Mutual Recognition Arrangement: Policy and Manag ement ILAC-P4:06/ /2017 ILAC International Laboratory Accreditation Cooperation ILAC is the international authority on laboratory, inspection body,
Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval
Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval UN Prequalification of Medicines, Diagnostics and Vaccines 6 th Consultative Stakeholder Meeting 4 April
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2016-12-14 11:29:24 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Equine
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-01-09 07:20:03 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Avian
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-02-11 01:00:00 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Infection
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-01-13 13:37:55 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Contagious
Laboratory Quality Assurance Manager & Laboratory Assessor RULES & HANDBOOK
EOQ Personnel Registration Scheme Laboratory Quality Assurance Manager & RULES & HANDBOOK Prepared by: Dr. Eugenia Soboleva, Quality Austria In accordance with the working group on EOQ product development
Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development
1 2 3 24 June 2010 EMA/CHMP/641298/2008 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug
A2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017
Laboratory Page 1 of 17 Laboratory December 6, 2017 2017 by A2LA All rights reserved. No part of this document may be reproduced in any form or by any means without the prior written permission of A2LA.
DESIGNATION AND RESPONSIBILITIES OF OIE NATIONAL FOCAL POINTS
Dr Mara Gonzalez OIE Regional Activities Department DESIGNATION AND RESPONSIBILITIES OF OIE NATIONAL FOCAL POINTS Regional Information Seminar for Recently Appointed OIE Delegates 18 20 February 2014,
PROFICIENCY TESTING 2013
Veterinary and Agrochemical Research Centre Groeselenberg 99 B 1180 Brussels (Ukkel) Tel: +32 (0)2 379 04 11 Fax : + 32 (0)2 379 06 70 http: // www.coda-cerva.be PROFICIENCY TESTING 2013 BLUE TONGUE VIRUS
A24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018
A24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018 Laboratory Name: Appendix Name: Appendix Number: Assessor: Date: Rev. 4.1 CALA CHECKLIST FOR MICROBIOLOGY Item 01 SAMPLING AND SAMPLE
EUROPEAN COMMISSION HEALTH & FOOD SAFETY. Directorate G Veterinary and International affairs. Unit G2- Animal health
EU-RL for Bovine Tuberculosis Ref. Ares(2016)855831 VISAVET v4-18/02/2016 EUROPEAN COMMISSION HEALTH & FOOD SAFETY Directorate G Veterinary and International affairs Unit G2- Animal health EUROPEAN UNION
Fish Health Laboratory Quality Assurance Process Basic Requirements for Tier I Prequalification
Fish Health Laboratory Quality Assurance Process Basic Requirements for Tier I Prequalification The purpose of the Quality Assurance/Quality Control Program (QA/QC) is to ensure the quality, reproducibility
IECEE OPERATIONAL DOCUMENT
IECEE OD-2048 Edition 1.5 2017-05-17 IECEE OPERATIONAL DOCUMENT IEC System of Conformity Assessment Schemes for Electrotechnical Equipment and Components (IECEE System) Utilization of Customers Testing
Diagnostics. Using Diagnostic Tests. Test Sensitivity and Specificity. Dr. Randall Singer Professor of Epidemiology
Executive Veterinary Program University of Illinois December 11-12, 2014 Outline Diagnostics Dr. Randall Singer Professor of Epidemiology review of sensitivity, specificity, predictive value test agreement
Quality Assurance of Investigational Medicinal Products. Sue McKenzie PPQA (A)
Quality Assurance of Investigational Medicinal Products Sue McKenzie PPQA (A) Agenda for Today IMP Regulations - CTD and Annex 13 Role of QP for IMP Challenges of IMP Manufacture for the QP IMP Regulations
INFECTIOUS MYONECROSIS
CHAPTER 9.4. INFECTIOUS MYONECROSIS Article 9.4.1. For the purposes of the Aquatic Code, infectious myonecrosis (IMN) means infection with infectious myonecrosis virus (IMNV). This virus is similar to
I: Glossary of Terms. 6 th ed. Paris, France: WOAH; Page 3
IDEXX SNAP* BVD Test 2010 IDEXX Laboratories, Inc. All rights reserved. 9534-00 IDEXX and Test With Confidence are trademarks or registered trademarks of IDEXX Laboratories, Inc. or its affiliates in the
Update on the IVDR. Sue Spencer
Update on the IVDR Sue Spencer Caution The new regulations are draft the principles have now been agreed but the Annexes are subject to minor changes Further details will be added later pre and post application
Quality management in veterinary testing laboratories
Quality management in veterinary testing laboratories EU / OIE & FAO Reference Laboratory for Brucellosis ANSES Maisons-Alfort, France The 4th FAO APHCA/OIE/DLD Regional Workshop on Brucellosis Diagnosis
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-01-24 13:17:41 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Infection
Role of an OIE Reference Laboratory Trichinellosis. Edoardo Pozio Istituto Superiore di Sanità Rome, Italy
Role of an OIE Reference Laboratory Trichinellosis Edoardo Pozio Istituto Superiore di Sanità Rome, Italy Historical background The OIE Reference Laboratory for Trichinellosis was appointed at the Istituto
2nd PPR & 4th FMD Roadmap Meetings for Middle East Amman, October PPR Global Eradication Programme Overview FAO/OIE PPR Secretariat
2nd PPR & 4th FMD Roadmap Meetings for Middle East Amman, 15 19 October 2017 PPR Global Eradication Programme Overview FAO/OIE PPR Secretariat Why eradicate PPR A destructive, fast spreading viral disease
Michael Robach Vice President, Corporate Food Safety and Regulatory Affairs Cargill incorporated Minneapolis, Minnesota, USA
78 SG/9 Original: English A PRIVATE SECTOR PERSPECTIVE ON PRIVATE STANDARDS SOME APPROACHES THAT COULD HELP TO REDUCE CURRENT AND POTENTIAL FUTURE CONFLICTS BETWEEN PUBLIC AND PRIVATE STANDARDS Michael
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2014 This report has been submitted : 2015-01-15 14:02:58 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Enzootic
Guidance for individual laboratories for transfer of quality control methods validated in collaborative trials with a view to implementing 3Rs
9 November 2017 EMA/CHMP/CVMP/3Rs/94436/2014 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Guidance for individual laboratories for transfer
ILAC-P10:2002. ILAC Policy on Traceability of Measurement Results
ILAC-P10:2002 ILAC Policy on Traceability of Measurement Results Copyright ILAC 2002 ILAC encourages the authorised reproduction of its publications, or parts thereof, by organisations wishing to use such
Measurement of uncertainty for Elisa Tests. University of Hasselt, Center for Statistics, Hasselt, Belgium
Appendix 58 Measurement of uncertainty for Elisa Tests Toussaint, J.F. 1*, Assam, P. 2, Caij, B. 1, Dekeyser, F. 1, Imberechts, H. 1, Knapen, K. 1, Goris N. 1, Molenberghs, G. 2, Mintiens, K. 1, De Clercq,
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2015 This report has been submitted : 2016-02-03 14:29:40 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Koi
OIE Regional Commission for Asia, the Far East and Oceania. Second Regional Work Plan Framework
OIE Regional Commission for Asia, the Far East and Oceania Second Regional Work Plan Framework 2016-2020 Second Regional Work Plan Framework 2016-2020 Adopted by the Regional Commission Members at 29th
Selection of a cutoff value for real-time polymerase chain reaction results to fit a diagnostic purpose: analytical and epidemiologic approaches
J Vet Diagn Invest 23:2 15 (2011) Selection of a cutoff value for real-time polymerase chain reaction results to fit a diagnostic purpose: analytical and epidemiologic approaches Charles G. B. Caraguel,
PPR Global Eradication Programme Overview
PPR Global Eradication Programme Overview Bouna Diop FAO/OIE PPR Global Secretariat Facts about Small ruminants Global small ruminant population: 2.1 billion head 59.7 % in Asia 33.8% in Africa 300 million
The FAO-OIE PPR Global Strategy. Outline 1. Establishment of the PPR WG and actions undertaken 2. Components of the strategy
The FAO-OIE PPR Global Strategy Outline 1. Establishment of the PPR WG and actions undertaken 2. Components of the strategy PPR has been included in the Regional 5 years Action Plans of Africa, the Middle
Welding Performance Qualification Test Administrators GUIDE FOR APPLICANTS
BRITISH COLUMBIA SAFETY AUTHORITY Welding Performance Qualification Test Administrators GUIDE FOR APPLICANTS Prepared by: Ed Hurd P.Eng. Provincial Safety Manager, Boilers Date: March 2, 2012 Controlled
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-01-12 12:56:01 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Ovine
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2014 This report has been submitted : 2015-01-19 12:51:35 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Infection
A Novel Approach to BSL-4 Research: Establishing a Clinical Core Services Group in High Containment
A Novel Approach to BSL-4 Research: Establishing a Clinical Core Services Group in High Containment Catherine M. Jett, Contractor Tunnell Government Services, Inc. Integrated Research Facility, Frederick,
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
Validating, Verifying, and Evaluating Your Test Methods: It s NOT a Regulatory Exercise!
Validating, Verifying, and Evaluating Your Test Methods: It s NOT a Regulatory Exercise! Pat Garrett, Ph.D., DABCC Renee Howell, Ph.D., MT(ASCP) SeraCare Life Sciences, Inc. AACC Annual Meeting July 29,
Wildlife Health Risk Assessment in Support of Decisions and Policies
Canadian Wildlife Health Cooperative Réseau Canadien de la santé de la faune Training Workshop for OIE Focal Points for Wildlife Wildlife Health Risk Assessment in Support of Decisions and Policies OIE
The New EU IVDR. Overview of the Main Changes & Clinical Data Requirements. Advance Regulatory Consulting Ltd.
Overview of the Main Changes & Clinical Data Requirements Advance Regulatory Consulting Ltd. : Timeline: Entry in to force Q2 (Apr) 2017 Adoption: +6m NB s apply for designation IVDs classified as Class
Recognition of Prior Learning (RPL) _v2.2
POLICY AND PROCEDURE Name: Recognition of Prior Learning (RPL) Approved by: Director of Product & Compliance Date Approved: 29/09/2015 Approved by: Compliance Manager Date Approved: 29/09/2015 Implementation
Title: How to assess a PQS testing laboratory Table of Content
Version: 01.05 Effective date: 08/07/2004 Page: 2 of 22 Table of Content 1.0 Purpose... 3 2.0 Scope... 3 3.0 Responsibility... 3 4.0 Documentation required... 4 5.0 Procedure... 4 5.1 Assessment Register...
Fibrinogen Universal Kit
Order references Reagents CONT FITUR-B00 Universal kit 1 x 50 ml R1 + 1 x 5 ml R2 FITUR-00 Universal kit 2 x 50 ml R1 + 1 x 15 ml R2 FITUR-C00 Universal kit 2 x 17 ml R1 + 1 x 4 ml R2 Other necessary products
National Veterinary Assay Laboratory Ministry of Agriculture, Forestry and Fisheries
National Veterinary Assay Laboratory Ministry of Agriculture, Forestry and Fisheries VICH General Principles and Harmonization of Criteria to Waive TABST for Vaccines for veterinary Use 1 1. WHAT Is VICH?
ISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 17511 First edition 2003-08-15 In vitro diagnostic medical devices Measurement of quantities in biological samples Metrological traceability of values assigned to calibrators
OIE STANDARDS ON ANIMAL IDENTIFICATION AND TRACEABILITY, AND THE LEVEL OF COMPLIANCE WITH THESE STANDARDS IN AFRICA
OIE STANDARDS ON ANIMAL IDENTIFICATION AND TRACEABILITY, AND THE LEVEL OF COMPLIANCE WITH THESE STANDARDS IN AFRICA M. Letshwenyo OIE Sub-Regional Representation for Southern Africa Gaborone, Botswana
QUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY
QUALITY CONTROL/QUALITY ASSURANCE IN THE MOLECULAR MICROBIOLOGY LABORATORY Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC
Replacing Analytical Methods for Release and Stability Testing CBER Perspective
Replacing Analytical Methods for Release and Stability Testing CBER Perspective Presentation at the CMC Strategy Forum January 27, 2014 Lokesh Bhattacharyya Chief, Lab of Analytical Chemistry and Blood
HUMAN RESOURCES COMMITTEE CHARTER
HUMAN RESOURCES COMMITTEE CHARTER Objective The objective of the Human Resources Committee is to assist the Board in discharging its duty to oversee the establishment of appropriate human resources policies
DEVELOPMENT AND OPTIMISATION OF NUCLEIC ACID DETECTION ASSAYS
NB: Version adopted by the World Assembly of Delegates of the OIE in May 2014 VALIDATION GUIDELINE 3.6.3. DEVELOPMENT AND OPTIMISATION OF NUCLEIC ACID DETECTION ASSAYS INTRODUCTION The OIE Validation Guidelines
EA MULTILATERAL AGREEMENT Facilitating cross border trade with reliable goods and services
EA MULTILATERAL AGREEMENT Facilitating cross border trade with reliable goods and services The importance of accreditation of conformity assessment bodies has substantially increased over the last decades.
REQUEST for the EuroRec Seal - Seal Level 2 Supplier Form
REQUEST for the Seal - Seal Level 2 Supplier Form This form needs to be completed and signed by the supplier requesting a Seal for an application. The application can be a complete EHR system with a complete
JAA Administrative & Guidance Material Section Six: Synthetic Training Devices (STD/FSTD), Part Three: Temporary Guidance Leaflet
LEAFLET NO. 9 (rev. 1): ADDITIONAL GUIDANCE ON QUALITY SYSTEMS FOR OPERATORS OF SYNTHETIC TRAINING DEVICES NOTE: The material contained in this Leaflet has been issued in accordance with Chapter 9 of Administrative
Variation Regulations (EU)
Variation Regulations (EU) Headlines of the Update APIC c view Hilde Vanneste APIC Task Force leader Hilde.Vanneste@its.jnj.com 1 Content Scope of regulation: Type of procedures and hence 2 strands Current
ISTA Tests for GMO seeds : New Rules Chapter and Handbook
ISTA Tests for GMO seeds : New Rules Chapter and Handbook René Mathis GEVES Groupe d Etude et de contrôle des Variétés Et des Semences ISTA Seminar on Molecular tools for seed quality & Seed health 2015-06-15
American Society of Cytopathology Core Curriculum in Molecular Biology
American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 4 Stephanie A. Hamilton, EdD, SCT, MB(ASCP) CM MD Anderson
Update on activities in ISO and CEN. Kirsten Mooijman
Update on activities in ISO and CEN Kirsten Mooijman Relevant groups in ISO and CEN ISO/TC34/SC9: ISO: International Standardisation Organisation TC34: Technical Committee 34 on Food products SC9: Subcommittee
OIML B 15 BASIC PUBLICATION. Edition 2006 (E) ORGANISATION INTERNATIONALE INTERNATIONAL ORGANIZATION
BASIC PUBLICATION OIML B 15 Edition 2006 (E) International Organization of Legal Metrology Strategic Plan Organisation Internationale de Métrologie Légale Plan Stratégique OIML B 15 Edition 2006 (E) ORGANISATION
Guidelines to establish a National Certification Centre for an assessment system based on the ELAQF Qualification Standards.
Guidelines to establish a National Certification Centre for an assessment system based on the ELAQF Qualification Standards. Page 2 of 8 Table of Contents Mission Statement 3 Introduction 3 Who can become
Clinical Trials application process, legislation & guidelines
Clinical Trials application process, legislation & guidelines IMB Clinical Trials Seminar 19 th June 2012 Elaine Breslin MB BCh (NUI), PhD, FRCPI Clinical Assessment Manager 19/06/2012 Slide 1 IMB Mission
PUBLIC-PRIVATE PARTNERSHIPS: EXPECTATIONS OF PRIVATE SECTOR PARTNERS FOR INTERNATIONAL ANIMAL HEALTH AND LIVESTOCK SECTOR DEVELOPMENT PROGRAMMES
85 SG/10 Original: English PUBLIC-PRIVATE PARTNERSHIPS: EXPECTATIONS OF PRIVATE SECTOR PARTNERS FOR INTERNATIONAL ANIMAL HEALTH AND LIVESTOCK SECTOR DEVELOPMENT PROGRAMMES S.J. Thevasagayam 1, I. Dieuzy-Labaye
BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE
The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate and/or remove potential viral contaminants. Experience and knowledge in selecting
TECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES
TECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES Approved By: Chief Executive Officer: Ron Josias Senior Manager: Christinah Leballo
International Association for Biologicals
International Association for Biologicals Presentation to Japanese Biologicals Forum by Tony Lubiniecki Tokyo, 16January2008 Scientific Society established in 1955 Headquartered in Switzerland Recognized
Billing Contact: Phone: Research Funding: NIH Funded Industry Funded Department Funded Short Study Protocol Title:
Please submit this application to CPRS@mednet.ucla.edu at least 2-3 weeks prior to the beginning of the research for approval. All UCLA studies using patient medical record numbers/identifiers must be
OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS
D i a g n o s t i c s a n d L a b o r a t o r y T e c h n o l o g y OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS Prequalification of Male Circumcision Devices PQMC_007
Selection and use of Ebola in vitro diagnostic (IVD) assays
EMERGENCY GUIDANCE Selection and use of Ebola in vitro diagnostic (IVD) assays June 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the material
Metrological Traceability and Assay Standardization in Laboratory Medicine. STRESA, ITALY May 24, 2013
Metrological Traceability and Assay Standardization in Laboratory Medicine STRESA, ITALY May 24, 2013 Standardization of ctni: Is there a light at the end of the tunnel? Jill Tate Pathology Queensland
How to Choose the Right Equipment/Platforms for your Laboratory
How to Choose the Right Equipment/Platforms for your Laboratory (A Public Hospital Laboratory Perspective) Michelle J. Francis Overview Public Hospital Pressures / Challenges Commercial vs In-house assays
ISTA Accreditation Standard for Seed Testing and Seed Sampling
INTERNATIONAL SEED TESTING ASSOCIATION (ISTA) Secretariat, Zürichstrasse 50, 8303 Bassersdorf, CH-Switzerland Phone: +41-44-838 60 00, Fax: +41-44-838 60 01, Email: ista.office@ista.ch, http://www.seedtest.org
Code and manual. Aquatic animals
Science as basis for decisions and diagnostic support Diagnostic support provided by the OIE Reference Laboratories and Collaborating Centres to OIE Member Countries (twinning) Roar Gudding Oslo, Norway
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL QUESTIONS. and ANSWERS
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, F2/SM D (2008) QUESTIONS and ANSWERS The rules governing medicinal products in the European Union VOLUME 2 NOTICE
EURASIAN ECONOMIC COMMISSION COUNCIL
EURASIAN ECONOMIC COMMISSION COUNCIL Working translation: DECISION October 9, 2014 No.94 Minsk On the Regulation on the Harmonized Procedure of Joint On-Site Inspections and of Taking Samples of Goods
Laboratory Validation. Chapter 16
Laboratory Validation Chapter 16 Importance The DNA profile is used to convict or free a suspect It must be perfect! No mistakes like we have in regular laboratories all the time Also DNA evidence must
European Regulations for Medicines. Place and Role of the European Pharmacopoeia in Europe Ph. Eur. concept
European Regulations for Medicines Place and Role of the European Pharmacopoeia in Europe Ph. Eur. concept Cathie VIELLE Head of the Ph. Eur. Department, EDQM THE PLACE OF THE PH. EUR. IN EUROPE 2 1 The
SAI Global Full Service Team
General information regarding elements of the certification process is described below. A degree of flexibility and options in the certification process are available so please feel free to contact us
Terms and conditions for laboratories appointed to undertake the testing of compost under the Compost Certification Scheme aligned to PAS 100 and the
Terms and conditions for laboratories appointed to undertake the testing of compost under the Compost Certification Scheme aligned to PAS 100 and the Compost Quality Protocol Renewable Energy Assurance
PHARMACEUTICAL REFERENCE STANDARDS
PHARMACEUTICAL REFERENCE STANDARDS 11 th International Symposium organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe 3-4 September 2012, Strasbourg,
Explanatory note on general fees payable to the European Medicines Agency
Explanatory note on general fees payable to the European Medicines Agency The fees, fee exemptions and definitions described in this explanatory note apply as of 1 June 2017 and are based on Council Regulation
Recast Medical Device directives Impacts on materiovigilance
Recast Medical Device directives Impacts on materiovigilance Journée Vigilance 23.03.2017 Valérie Nys Revision of the EU Medical Devices Legislation Directive 90/385/EEC on active implantable medical devices
Recognition of Prior Learning (RPL) & Credit Transfers
Recognition of Prior Learning (RPL) & Credit Transfers Content 1. Definition of Recognition of Prior Learning (RPL) and Credit Transfer 2. Recognition of Prior Learning (RPL) 3. Credit Transfer 4. RPL
A2LA. P113a Policy on Reference Material Traceability for Life Sciences Testing Laboratories
Page 1 of 6 Introduction The Life Sciences Advisory Committee realizes that the traceability of reference materials (RMs) per the requirements of ISO/IEC 17025:2005 (Section 5.6.3) or ISO/IEC 17025:2017(Section
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report h been submitted : 2017-01-10 18:49:13 Name of disee (or topic) for which you are a designated OIE Reference Laboratory: Leishmaniosis
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
LEARNING. Recognition of Prior Learning Policy and Procedure
LEARNING Recognition of Prior Learning Policy and Procedure The Association of Superannuation Funds of Australia Limited (ASFA) PO Box 1485, Sydney NSW 2001 T +61 2 9264 9300 or 1800 812 798 (outside Sydney)
Flexible, robust solutions from BSI. An In Vitro Diagnostic Notified Body. Expertise and experience. IVD regulatory solutions
Flexible, robust solutions from BSI An In Vitro Diagnostic Notified Body Expertise and experience IVD regulatory solutions Updated May 2017 Your guide to the In Vitro Diagnostic Directive The purpose of